Hemodynamic Indices of Myocardial Dysfunction Correlate with Dipyridamole Thallium-201 SPECT

Journal of Nuclear Medicine

Volumn 37, Issue 5, 1996, Pages 723-729

  Chin, Bennett B ^a   Moshin, Jamil ^b   Bouchard, Matthew ^b   Berlin, Jesse A ^b   Araujo, Luis I ^b   Alavi, Abass ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

Dipyridamole; Hemodynamics; SPECT; Thallium 201

Indexed keywords

DIAGNOSTIC AGENT; DIPYRIDAMOLE; THALLIUM; VASODILATOR AGENT;

ARTICLE; CASE CONTROL STUDY; COMPARATIVE STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; EXERCISE TEST; FEMALE; HEART; HEART CATHETERIZATION; HEART LEFT VENTRICLE FUNCTION; HEMODYNAMICS; HUMAN; LUNG; MALE; MIDDLE AGED; PHYSIOLOGY; RISK FACTOR; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

CASE-CONTROL STUDIES; CORONARY CIRCULATION; CORONARY DISEASE; DIPYRIDAMOLE; EXERCISE TEST; FEMALE; HEART; HEART CATHETERIZATION; HEMODYNAMIC PROCESSES; HUMANS; LUNG; MALE; MIDDLE AGED; RISK FACTORS; THALLIUM RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VASODILATOR AGENTS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0030138471     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Boucher CA, Zir LM, Beller GA, Okada RD, McKusick KA, Strauss HW, Pohost GM. Increased lung uptake of thallium-201 during exercise myocardial imaging. Clinical, hemodynamic and angiographic implications in patients with coronary artery disease. Am J Cardiol 1980;46:189-196.
2. Bingham JB, McKusick KA, Strauss HW, Boucher CA, Pohost GM. Influence of coronary artery disease on pulmonary uptake of thallium-201. Am J Cardiol 1980;46:821-826.
3. Kushner FG, Okada RD, Kirshenbaum HD, Boucher CA, Strauss HW, Pohost GM. Lung thallium-201 uptake after stress testing in patients with coronary artery disease. Circulation 1981;63:341-347.
4. Canhasi B, Dae M, Botvinick E. et al. Interaction of "supplementary" scintigraphic indicators of ischemia and stress electrocardiography in the diagnosis of multivessel coronary disease. J Am Coll Cardiol 1985;6:581-588.
5. Homma S, Kaul S, Boucher C. Correlates of lung/heart ratio of thallium-201 in coronary artery disease. J Nucl Med 1987;28:1531-1535.
6. Gibson R, Watson D, Carabello B, Holt D, Beller G. Clinical implications of increased lung uptake of thallium-201 during exercise scintigraphy two wk after myocardial infarction. Am J Cardiol 1982;49:1586-1593.
7. Diamond GA, Forrester JS. Analysis of probability as an aid in the clinical diagnosis of coronary' artery disease. N Engl J Med 1979;300:1350-1358.
8. Kahn JK, Carry MM, McGhie I, Pippin JJ, Akers MS, Corbett JR. Quantitation of postexercise lung thallium-201 uptake during single photon emission computed tomography. J Nucl Med 1989;30:288-294.
9. Iskandrian AS, Heo J, Nguyen T, Lyons E, Paugh E. Left ventricular dilatation and pulmonary thallium uptake after single-photon emission computed tomography using thallium-201 during adenosine-induced coronary hyperemia. Am J Cardiol 1990;66:807-811.
10. Ranhosky A, Kempthorne-Rawson J. The safety of intravenous dipyridamole thallium myocardial perfusion imaging. Circulation 1990;81:1205-1209.
11. Slulsky RA, Higgins CB. Thallium scintigraphy in experimental toxic pulmonary edema: relationship to extravascular pulmonary fluid. J Nucl Med 1984;25:581-591.
12. Gill JB, Ruddy TD, Newell JB, Finkelstein DM, Strauss HW, Boucher CA. Prognostic importance of thallium uptake by the lungs during exercise in coronary artery disease. N Engl J Med 1987;317:1485-1489.
13. Kaul S, Homma S, Leavitt M, Finkelstein D, Okada RD, Boucher CA. Superiority of quantitative exercise thallium-201 variables in determining long-term prognosis in ambulatory patients with chest pain: a comparison with cardiac catheterization. J Am Coll Cardiol 1988;12:25-34.
14. Brown KA, Boucher CA, Okada RD, Guiney TE, Newell JB, Strauss HW, Pohost GM. Prognostic value of exercise thallium-201 imaging in patients presenting for evaluation of chest pain. J Am Coll Cardiol 1983;1:994-1001.
15. Nygaard TW, Gibson RS, Ryan JM, Gascho JA, Watson DD, Beller GA. Prevalence of high-risk thallium-201 scintigraphic findings in left main coronary artery stenosis: comparison with patients with multiple- and single-vessel coronary artery disease. Am J Cardiol 1984;53:462-469.
16. Okada RD, Yu-Hua D, Boucher CA, Pohost GM. Significance of increased lung thallium-201 activity on serial cardiac images after dipyridamole treatment in coronary artery disease. Am J Cardiol 1984;53:470-475.
17. Villanueva FS, Kaul S, Smith WH, Watson DD, Varma SK, Beller GA. Prevalence and correlates of increased lung/heart ratio of thallium-201 during dipyridamole stress imaging for suspected coronary artery disease. Am J Cardiol 1990;66:1324-1328.
18. Pennell DJ, Ell PJ. Whole-body imaging of thallium-201 after six different stress regimens. J Nucl Med 1994;35:425-428.
19. Nishimura S, Mahmarian JJ, Verani MS. Significance of increased lung thallium uptake during adenosine thallium-201 scintigraphy. J Nucl Med 1992;33:1600-1607.
20. Brown KA, Boucher CA, Okada RA, Strauss HW, Pohost GM. Quantification of pulmonary thallium-201 activity after upright exercise in normal persons: importance of peak heart rate and propranolol usage in defining normal values. Am J Cardiol 1984;53:1678-1682.
21. Nordrehaug JE, Danielsen R, Vik MH. Physiological inverse relationship between heart rate and thallium-201 lung uptake, clearance and lung/myocardial uptake ratio. Eur Heart J 1990;11:628-633.
22. Ruddy TD, Gill JB, Finkelstein DM, Strauss HW, McKusick KA, Okada RD, Boucher CA. Myocardial uptake and clearance of thallium-201 in normal subjects: comparison of dipyridamole-induced hyperemia with exercise stress. J Am Coll Cardiol 1987;10:547-556.
23. Lee J, Chae SC, Lee K, Heo J, Iskandrian AS. Biokinetics of thallium-201 in normal subjects: comparison between adenosine, dipyridamole, dobutamine and exercise. J Nucl Med 1994;35:535-541.
24. Wilson RA, Okada RD, Boucher CA, Strauss HW, Pohost GM. Radionuclidedetermined changes in pulmonary blood volume and thallium lung uptake in patients with coronary artery disease. Am J Cardiol 1981;51:741-748.
25. Miller DD, Scott RA, Riesmeyer JS, Chaudhuri TK, Blumhardt R, Boucher CA, O'Rourke RA. Acute hemodynamic changes during intravenous dipyridamole thallium imaging early ater infarction. Am Heart J 1989;118:686-694.
26. Beller GA, Holzgrefe HH, Watson DD. Intrinsic washout rates of thallium-201 in normal and ischemic myocardium after dipyridamole-induced vasodilatation. Circulation 1985;71:378-386.
27. Beller GA, Holzgrefe BS, Watson DD. Effects of dipyridamole-induced vasodilatation on myocardial uptake and clearance kinetics of thallium-201. Circulation 1983;68:1328-1338.
28. Becker LC. Effect of nitroglycerin and dipyridamole on regional left ventricular blood flow during coronary artery occlusion. J Clin Invest 1976;58:1287-1296.
29. Jain D, Lahiri A, Raftery EB. et al. Clinical and prognostic significance of lung thallium uptake on rest imaging in acute myocardial infarction. Am J Cardiol 1990;65:154-159.
30. Leppo JA, O'Brien J, Rothendler KA, Getchell JD, Lee VW. Dipyridamole-thallium-201 scintigraphy in the prediction of future cardiac events after acute myocardial infarction. N Engl J Med 1984;310:1014-1018.
31. Boucher CA, Brewster DC, Darling RC, Okada RD, Strauss HW, Pohost GM. Determination of cardiac risk by dipyridamole-thallium imaging before peripheral vascular surgery. N Engl J Med 1985;312:389-394.
32. Leppo J, Plaua J, Gionet M, Tumolo J, Paraskos JA, Cutler BS. Noninvasive evaluation of cardiac risk before elective vascular surgery. J Am Coll Cardiol 1987;9:269-276.
33. Younis LT, Byers S, Shaw L, Barth G, Goodgold H, Chaitman BR. Prognostic value of intravenous dipyridamole thallium scintigraphy after an acute myocardial ischemic event. Am J Cardiol 1989;64:161-166.
34. Hendel RC, Layden JJ, Leppo JA. Prognostic value of dipyridamole thallium scintigraphy for evaluation of ischemic heart disease. J Am Coll Cardiol 1990;15:109-116.
35. Brown KA. Prognostic value of thalliurn-201 myocardial perfusion imaging. Circulation 1991;83:363-381.
36. Chouraqui P, Rodriques EA, Berman DS, Maddahi J. Significance of dipyridamoleinduced transient dilation of the left ventricle during thallium-201 scintigraphy in suspected coronary artery disease. Am J Cardiol 1990;66:689-694.
37. Stratton JR, Speck SM, Caldwell JH, et al. Relation of global and regional left ventricular function to tomographic thallium-201 myocardial perfusion in patients with prior myocardial infarction. J Am Coll Cardiol 1988;12:71-77.
38. Younis LT, Byers S, Shaw L, Barth G, Goodgold H, Chaitman BR. Prognostic importance of silent myocardial ischemia detected by intravenous dipyridamole thallium myocardial imaging in asymptomatic patients with coronary artery disease. J Am Coll Cardiol 1989;14:1635-1641.
39. Iskandrian AS, Chac SC, Heo J, et al. Independent and incremental prognostic value of exercise single-photon emission computed tomographic thallium imaging in coronary artery disease. J Am Coll Cardiol 1993;22:665-670.
40. Ilmer B, Rcijs AE, Fioretti P, Reiber JH. Comparative study of three different approaches on the estimation of the lung-heart ratio in thallium-201 scintigrams in relation to the extent of coronary artery disease and left ventricular function. Eur J Nucl Med 1991;18:252-258.
41. Mannting F. A new method of quantification of pulmonary thallium uptake in myocardial SPECT studies. Eur J Nucl Med 1990;16:213-222.